Original Article
Author Details :
Volume : 10, Issue : 2, Year : 2023
Article Page : 168-174
https://doi.org/10.18231/j.ijca.2023.033
Abstract
Background: The erector spinae plane block (ESPB) can be used to reduce pain and opioid requirements after abdominal surgery.The study was undertaken to assess post-operative analgesia of ESPB in patients undergoing laparotomy under general anaesthesia.
Materials and Methods: A total 34 patients of either sex, age between 20-60 years, ASA status 1 and 2 undergoing exploratory laparotomy were included and equally randomised into two study groups of 17 each. Group A received ESPB with 0.25% inj. bupivacaine 20ml on each side (Total 40ml 0.25% inj. Bupivacaine) and group B with no intervention.
Results: The mean VAS Score was <4cm>4cm all intervals till 24hr in Group B. Thus, quality of analgesia was better in Group A. In Group B, 10 (58.82%) out of 17 patients required first dose of tramadol at 1½ hr as compared to none in Group A. At 24hr, all patients in Group B received tramadol as rescue analgesic compared to only 3 (17.64%) in Group A. The cumulative tramadol consumption was significantly low in Group A (5.88±13.71mg) than Group B (191.76±40.65mg). Complications like nausea, vomiting was more in Group B because of increased tramadol consumption.
Conclusion: ESPB is a simple, easy, convenient option, when utilized as a component of multi-modal analgesia for pain relief in abdominal surgery.
Keywords: Erector spinae plane block, Analgesia, Laparotomy, Bupivacaine, VAS score, Tramadol.
How to cite : Cham S C, Raikwar M A, Atkari R S, Marathe A P, Nayar S S, Sangawar M A, Cham C, A prospective randomized trial of evaluation of post-operative analgesia of erector spinae plane block in patients undergoing laparotomy. Indian J Clin Anaesth 2023;10(2):168-174
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.